Opaleye Management as of Sept. 30, 2017
Portfolio Holdings for Opaleye Management
Opaleye Management holds 34 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Blueprint Medicines (BPMC) | 18.1 | $51M | 735k | 69.67 | |
| Axogen (AXGN) | 13.5 | $38M | 2.0M | 19.35 | |
| Fibrogen (FGEN) | 6.8 | $19M | 360k | 53.80 | |
| Immunomedics | 4.4 | $13M | 899k | 13.98 | |
| Loxo Oncology | 4.2 | $12M | 130k | 92.12 | |
| Codexis (CDXS) | 4.0 | $11M | 1.7M | 6.65 | |
| Corium Intl | 3.6 | $10M | 920k | 11.08 | |
| Momenta Pharmaceuticals | 3.3 | $9.3M | 500k | 18.50 | |
| Sangamo Biosciences (SGMO) | 3.1 | $8.7M | 580k | 15.00 | |
| Agios Pharmaceuticals (AGIO) | 3.1 | $8.7M | 130k | 66.75 | |
| Cytomx Therapeutics (CTMX) | 2.9 | $8.2M | 450k | 18.17 | |
| Strongbridge Bioph shs usd | 2.9 | $8.1M | 1.2M | 6.90 | |
| Eagle Pharmaceuticals (EGRX) | 2.7 | $7.8M | 130k | 59.64 | |
| Chimerix (CMRX) | 2.6 | $7.4M | 1.4M | 5.25 | |
| Foamix Pharmaceuticals | 2.2 | $6.3M | 1.1M | 5.55 | |
| Xoma Corp Del (XOMA) | 2.2 | $6.3M | 320k | 19.65 | |
| Theravance Biopharma (TBPH) | 2.2 | $6.2M | 180k | 34.24 | |
| Cymabay Therapeutics | 1.9 | $5.4M | 665k | 8.05 | |
| Audentes Therapeutics | 1.8 | $5.0M | 180k | 28.01 | |
| Synlogic | 1.7 | $4.8M | 250k | 19.01 | |
| Enanta Pharmaceuticals (ENTA) | 1.7 | $4.7M | 100k | 46.80 | |
| Deciphera Pharmaceuticals | 1.5 | $4.1M | 217k | 18.99 | |
| Ardelyx (ARDX) | 1.4 | $3.9M | 700k | 5.60 | |
| Acceleron Pharma | 1.3 | $3.8M | 102k | 37.32 | |
| Insmed (INSM) | 1.3 | $3.7M | 120k | 31.21 | |
| Inotek Pharmaceuticals | 1.1 | $3.2M | 1.8M | 1.78 | |
| Neuroderm Ltd F | 1.0 | $2.7M | 70k | 38.90 | |
| Aratana Therapeutics | 0.9 | $2.6M | 420k | 6.13 | |
| Selecta Biosciences | 0.6 | $1.7M | 95k | 18.24 | |
| Syros Pharmaceuticals | 0.6 | $1.7M | 117k | 14.72 | |
| Intercept Pharmaceuticals In | 0.6 | $1.6M | 28k | 58.03 | |
| ArQule | 0.5 | $1.4M | 1.2M | 1.11 | |
| Quotient Technology | 0.2 | $542k | 110k | 4.93 | |
| Biolinerx Ltd-spons | 0.1 | $280k | 250k | 1.12 |
